Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Astellas Announces Positive Topline Results for Global Phase 3 Trial of Roxadustat in Chronic Kidney Disease (CKD) Patients with Anemia not on Dialysis
TOKYO, September 20, 2018 - Astellas Pharma Inc.
EU approves fifth copy of AbbVie's $18 billion drug Humira
LONDON (Reuters) - Europe has approved a fifth copy of AbbVie’s $18-billion-a-year biologic drug Humira – the world’s best-selling prescription medicine – ramping up competition among ...
Allergan, Sosei suspend clinical development of dementia drug
Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.
Cochrane Collaboration Expels Cofounder, Prompts Resignations
Physician Peter Gøtzsche, a board member of the organization, has been an outspoken critic of certain vaccines and of the pharma industry in general.
Actelion’s Opsumit shows promise in portopulmonary hypertension
Actelion has unveiled new data showing that the first ever randomised, controlled clinical trial investigating Opsumit as potential treatment for portopulmonary hypertension (PoPH) hit its pri...
Almirall steps into psoriasis market with Ilumetri approval
The European Commission has approved Almirall’s Ilumetri for moderate-to-severe chronic plaque psoriasis.
Phase III trial results of PT010 combination therapy in COPD
AstraZeneca has announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide/ glycopyrronium/formoterol ...
Clovis Oncology, execs to pay $20 million to settle SEC charges
WASHINGTON (Reuters) - U.
Takeda gets China's approval for $62 billion Shire purchase
Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10...
Macron announces changes to France's health care system
French President Emmanuel Macron on Tuesday unveiled plans to make France's health care system, considered one of the best in the world, more efficient and sustainable for the next 50 years.
Daily low-dose aspirin found to have no effect on healthy life span in older people
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent liv...
AZ to file triple combination therapy for COPD
AstraZeneca has unveiled late-stage data backing use of its triple combination therapy PT010 in patients with chronic obstructive pulmonary disease (COPD).
455
456
457
458
459
460
461
462
463
